Report Detail
Global Herceptin Biosimilar Market Growth 2019-2024
- RnM3380137 |
- 06 May, 2019 |
- Global |
- 132 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
According to this study, over the next five years the Herceptin Biosimilar market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Herceptin Biosimilar business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Herceptin Biosimilar market by product type, application, key manufacturers and key regions and countries.
This study considers the Herceptin Biosimilar value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinics
Oncology Centers
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Herceptin Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Herceptin Biosimilar market by identifying its various subsegments.
Focuses on the key global Herceptin Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Herceptin Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Herceptin Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Herceptin Biosimilar Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Herceptin Biosimilar Consumption 2014-2024
- 2.1.2 Herceptin Biosimilar Consumption CAGR by Region
- 2.2 Herceptin Biosimilar Segment by Type
- 2.2.1 Breast Cancer
- 2.2.2 Colorectal Cancer
- 2.2.3 Leukemia
- 2.2.4 Lymphoma
- 2.2.5 Other
- 2.3 Herceptin Biosimilar Consumption by Type
- 2.3.1 Global Herceptin Biosimilar Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Herceptin Biosimilar Sale Price by Type (2014-2019)
- 2.4 Herceptin Biosimilar Segment by Application
- 2.4.1 Hospital & Clinics
- 2.4.2 Oncology Centers
- 2.4.3 Other
- 2.5 Herceptin Biosimilar Consumption by Application
- 2.5.1 Global Herceptin Biosimilar Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Herceptin Biosimilar Value and Market Share by Application (2014-2019)
- 2.5.3 Global Herceptin Biosimilar Sale Price by Application (2014-2019)
3 Global Herceptin Biosimilar by Manufacturers
- 3.1 Global Herceptin Biosimilar Sales Market Share by Manufacturers
- 3.1.1 Global Herceptin Biosimilar Sales by Manufacturers (2017-2019)
- 3.1.2 Global Herceptin Biosimilar Sales Market Share by Manufacturers (2017-2019)
- 3.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers
- 3.2.1 Global Herceptin Biosimilar Revenue by Manufacturers (2017-2019)
- 3.2.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers (2017-2019)
- 3.3 Global Herceptin Biosimilar Sale Price by Manufacturers
- 3.4 Global Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
- 3.4.1 Global Herceptin Biosimilar Manufacturing Base Distribution and Sales Area by Manufacturers
- 3.4.2 Players Herceptin Biosimilar Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Herceptin Biosimilar by Regions
- 4.1 Herceptin Biosimilar by Regions
- 4.1.1 Global Herceptin Biosimilar Consumption by Regions
- 4.1.2 Global Herceptin Biosimilar Value by Regions
- 4.2 Americas Herceptin Biosimilar Consumption Growth
- 4.3 APAC Herceptin Biosimilar Consumption Growth
- 4.4 Europe Herceptin Biosimilar Consumption Growth
- 4.5 Middle East & Africa Herceptin Biosimilar Consumption Growth
5 Americas
- 5.1 Americas Herceptin Biosimilar Consumption by Countries
- 5.1.1 Americas Herceptin Biosimilar Consumption by Countries (2014-2019)
- 5.1.2 Americas Herceptin Biosimilar Value by Countries (2014-2019)
- 5.2 Americas Herceptin Biosimilar Consumption by Type
- 5.3 Americas Herceptin Biosimilar Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Herceptin Biosimilar Consumption by Countries
- 6.1.1 APAC Herceptin Biosimilar Consumption by Countries (2014-2019)
- 6.1.2 APAC Herceptin Biosimilar Value by Countries (2014-2019)
- 6.2 APAC Herceptin Biosimilar Consumption by Type
- 6.3 APAC Herceptin Biosimilar Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Herceptin Biosimilar by Countries
- 7.1.1 Europe Herceptin Biosimilar Consumption by Countries (2014-2019)
- 7.1.2 Europe Herceptin Biosimilar Value by Countries (2014-2019)
- 7.2 Europe Herceptin Biosimilar Consumption by Type
- 7.3 Europe Herceptin Biosimilar Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Herceptin Biosimilar by Countries
- 8.1.1 Middle East & Africa Herceptin Biosimilar Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Herceptin Biosimilar Value by Countries (2014-2019)
- 8.2 Middle East & Africa Herceptin Biosimilar Consumption by Type
- 8.3 Middle East & Africa Herceptin Biosimilar Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Herceptin Biosimilar Distributors
- 10.3 Herceptin Biosimilar Customer
11 Global Herceptin Biosimilar Market Forecast
- 11.1 Global Herceptin Biosimilar Consumption Forecast (2019-2024)
- 11.2 Global Herceptin Biosimilar Forecast by Regions
- 11.2.1 Global Herceptin Biosimilar Forecast by Regions (2019-2024)
- 11.2.2 Global Herceptin Biosimilar Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Herceptin Biosimilar Forecast by Type
- 11.8 Global Herceptin Biosimilar Forecast by Application
12 Key Players Analysis
- 12.1 Amgen
- 12.1.1 Company Details
- 12.1.2 Herceptin Biosimilar Product Offered
- 12.1.3 Amgen Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Amgen News
- 12.2 AryoGen Biopharma
- 12.2.1 Company Details
- 12.2.2 Herceptin Biosimilar Product Offered
- 12.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 AryoGen Biopharma News
- 12.3 Biocon
- 12.3.1 Company Details
- 12.3.2 Herceptin Biosimilar Product Offered
- 12.3.3 Biocon Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Biocon News
- 12.4 Celltrion
- 12.4.1 Company Details
- 12.4.2 Herceptin Biosimilar Product Offered
- 12.4.3 Celltrion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Celltrion News
- 12.5 Gedeon Richter
- 12.5.1 Company Details
- 12.5.2 Herceptin Biosimilar Product Offered
- 12.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Gedeon Richter News
- 12.6 Genor Biopharma
- 12.6.1 Company Details
- 12.6.2 Herceptin Biosimilar Product Offered
- 12.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Genor Biopharma News
- 12.7 Mabion
- 12.7.1 Company Details
- 12.7.2 Herceptin Biosimilar Product Offered
- 12.7.3 Mabion Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Mabion News
- 12.8 Mylan
- 12.8.1 Company Details
- 12.8.2 Herceptin Biosimilar Product Offered
- 12.8.3 Mylan Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Mylan News
- 12.9 Roche
- 12.9.1 Company Details
- 12.9.2 Herceptin Biosimilar Product Offered
- 12.9.3 Roche Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Roche News
- 12.10 The Instituto Vital Brazil
- 12.10.1 Company Details
- 12.10.2 Herceptin Biosimilar Product Offered
- 12.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 The Instituto Vital Brazil News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Herceptin Biosimilar . Industry analysis & Market Report on Herceptin Biosimilar is a syndicated market report, published as Global Herceptin Biosimilar Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Herceptin Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
